» Articles » PMID: 9703338

Enhanced Responsiveness of Blood Pressure to Sodium Intake and to Angiotensin II is Associated with Insulin Resistance in IDDM Patients with Microalbuminuria

Overview
Journal Diabetes
Specialty Endocrinology
Date 1998 Aug 14
PMID 9703338
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

We assessed blood pressure (BP), body weight, renal hemodynamics, and insulin sensitivity (by euglycemic-hyperinsulinemic clamp) in nine normoalbuminuric and seven microalbuminuric IDDM patients after 6 days on a low-sodium diet (20 mEq) and after 6 days on a high-sodium diet (250 mEq). In microalbuminuric but not in normoalbuminuric IDDM patients, switching from a low to a high-sodium diet was associated with a significant increase in mean BP (from 92 +/- 3 to 101 +/- 4 mmHg; P < 0.001) and in body weight (2.91 +/- 0.63 vs. 1.47 +/- 0.26 kg; P < 0.05). Moreover, under high-sodium conditions, angiotensin II infusion (3 ng x kg(-1) x min(-1)) caused a greater increase in mean BP (14 +/- 2 vs. 7.4 +/- 1 mmHg; P < 0.05) and a smaller reduction in renal plasma flow (-122 +/- 29 vs. -274 +/- 41 ml x min(-1) x 1.73 m2; P < 0.05) in microalbuminuric than in normoalbuminuric IDDM patients. Under low sodium conditions, aldosterone increments after angiotensin II infusion were lower (P < 0.05) in microalbuminuric than in normoalbuminuric IDDM patients. Insulin-mediated glucose disposal was not affected by sodium dietary content, but it was lower in microalbuminuric (P < 0.05) than in normoalbuminuric IDDM patients. The salt-induced changes in mean BP were related to insulin sensitivity (r = -0.78; P < 0.001). In conclusion, in IDDM patients, microalbuminuria is associated with 1) an increased responsiveness of BP to salt intake and angiotensin II, 2) impaired modulation of renal blood flow, and 3) insulin resistance. Therefore, salt sensitivity in IDDM patients clusters with other factors that are likely to play an important role in the pathogenesis of diabetic nephropathy and its cardiovascular complications.

Citing Articles

New Perspectives on Obesity-Associated Nephropathy from Pathophysiology to Therapeutics: Revealing the Promise of GLP-1 RA Therapy.

Ren L, Ju F, Liu S, Cai Y, Gang X, Wang G Drug Des Devel Ther. 2024; 18:4257-4272.

PMID: 39347536 PMC: 11437658. DOI: 10.2147/DDDT.S476815.


Triglyceride-Glucose Index Associated with Future Renal Function Decline in the General Population.

Yoshida D, Ikeda S, Shinohara K, Kazurayama M, Tanaka S, Yamaizumi M J Gen Intern Med. 2024; 39(16):3225-3233.

PMID: 38782808 PMC: 11618565. DOI: 10.1007/s11606-024-08809-4.


Excess Salt Intake Activates IL-21-Dominant Autoimmune Diabetogenesis via a Salt-Regulated Ste20-Related Proline/Alanine-Rich Kinase in CD4 T Cells.

Ciou J, Chien M, Hsu C, Liu Y, Dong J, Tsai S Diabetes. 2024; 73(4):592-603.

PMID: 38241027 PMC: 11031440. DOI: 10.2337/db23-0599.


The effect of a low versus high sodium diet on blood pressure in diabetic patients: A systematic review and meta-analysis of clinical trials.

Gholizadeh-Moghaddam M, Shahdadian F, Shirani F, Hadi A, Clark C, Rouhani M Food Sci Nutr. 2023; 11(4):1622-1633.

PMID: 37051341 PMC: 10084959. DOI: 10.1002/fsn3.3212.


Altered dietary salt intake for preventing diabetic kidney disease and its progression.

Hodson E, Cooper T Cochrane Database Syst Rev. 2023; 1:CD006763.

PMID: 36645291 PMC: 9841968. DOI: 10.1002/14651858.CD006763.pub3.